Pharmabiz13m
Caristo Diagnostics’ CaRi-Plaque technology, an AI-assisted image analysis application to aid the diagnosis of CAD receives US FDA 510(k) clearance
Stamford, Connecticut Wednesday, March 12, 2025, 15:00 Hrs [IST] ...
Health notes
Two-day conference on cardiology ...
British Heart Foundation16h
Cardiology waiting times in Scotland are highest level on record
More than 24,000 people were waiting for a cardiology appointment as of September 2024, a 252% increase on the number waiting ...
Westfair Communications16h
The Scarsdale teen at the ‘heart’ of a health movement
Humanitarianism is about building the kind of world we want to live in. Change isn’t optional but a responsibility. So…let’s act with urgency, compassion and purpose. The heart of the movement is ...
FDA clears Caristo’s AI-powered CAD diagnostic software
The software can determine the extent and severity of coronary plaque build-up implicated in coronary artery disease.
Caristo Diagnostics: Caristo Secures FDA Clearance, Ushering in a New Era of AI-Powered Heart Attack Prevention
FDA 510(k) clearance of Caristo's CaRi-Plaque technology advances AI innovator's U.S. commercialization, as it looks to roll out to hospitals, health systems and longevity clinicsThe CaRi-Plaque ...
Caristo Secures FDA Clearance, Ushering in a New Era of AI-Powered Heart Attack Prevention
Caristo Diagnostics, on a mission to transform the diagnosis and treatment of cardiovascular disease, today announced it has ...